Get started
Author

Hemangi R. Panchmatia

Observed names: H Panchmatia, H. Panchmatia, H.R. Panchmatia, Hemangi Panchmatia, Panchmatia, H R, Panchmatia, Hemangi R.
Observed institution: Alkermes (United States)
ORCID: 0009-0007-4501-9484
Observed ORCID: 0009-0007-4501-9484
OpenAlex ID: A5085124680
Economic model of a birth cohort screening program for hepatitis C virus
2011 · Lisa J. McGarry, Vivek S. Pawar, et al. · Hepatology · 111
PDF
Aflibercept vs. Ranibizumab: cost‐effectiveness of treatment for wet age‐related macular degeneration in Sweden
2016 · Hemangi R. Panchmatia, Karen M. Clements, et al. · Acta Ophthalmologica · 18
The Clinical and Economic Burden of Peripheral T-Cell Lymphoma: a Systematic Literature Review
2021 · Ajibade O Ashaye, Heather Burnett, et al. · Future Oncology · 5
Cost-Effectiveness Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In The US
2013 · R. Vitti, K.M. Clements, et al. · Value in Health · 4
Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder
2024 · Michael J. Doane, Marco Boeri, et al. · BMC Psychiatry · 2
PDF
Healthcare Resource Utilization 6 Months Before and After Olanzapine/Samidorphan Initiation: Real-World Assessment of Patients with Schizophrenia or Bipolar I Disorder
2025 · Andrew J. Cutler, Hemangi R. Panchmatia, et al. · Advances in Therapy · 1
PDF
SA65 Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder
2024 · AJ Cutler, H Panchmatia, et al. · Value in Health · 1
Cost-Effectiveness of Intravitreal Aflibercept in Treating Neovascular Age-Related Macular Degeneration in Sweden
2013 · K.M. Clements, E.M. Hulbert, et al. · Value in Health · 1
Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older
2013 · R. Vitti, K.M. Clements, et al. · Value in Health · 1
Co138 Real-world Comparison of Olanzapine/samidorphan Vs Olanzapine: an Assessment of Treatment Patterns and Acute Care Events Among Patients With Schizophrenia or Bipolar I Disorder
2026 · Hemangi Panchmatia, Rakesh Jain, et al. · Value in Health
Co95 Real-world Impact of Olanzapine and Samidorphan on Rates of Relapse Among Young Adults With Schizophrenia or Bipolar I Disorder
2026 · Andrew J. Cutler, Hemangi Panchmatia, et al. · Value in Health
RWD82 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder
2025 · Rakesh Jain, Hemangi R. Panchmatia, et al. · Value in Health
RWD47 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia
2025 · Andrew J. Cutler, Hemangi R. Panchmatia, et al. · Value in Health
Matched Comparison Examining the Effect of Obesity on Clinical, Economic, and Humanistic Outcomes in Patients with Bipolar I Disorder
2024 · Michael J. Doane, Adam Jauregui, et al. · Advances in Therapy
PDF
PCR46 Preferences for Attributes of Oral Antipsychotic Treatments: Survey Results of Patients Living with Schizophrenia or Bipolar I Disorder
2023 · M. Doane, M. Boeri, et al. · Value in Health
PDF
Pcn15 Efficacy, Effectiveness, and Safety of Frontline Treatments for Peripheral T-cell Lymphoma
2020 · A.O. Ashaye, H. Panchmatia, et al. · Value in Health
Pms34 Taltz® (ixekizumab) for Treatment of Psoriatic Arthritis in the United States: a Budget Impact Analysis
2020 · M. Murage, H. Panchmatia, et al. · Value in Health
Pcn275 the Global Epidemiology of Peripheral T-cell Lymphoma: a Systematic Review
2019 · S. Abogunrin, H. Panchmatia, et al. · Value in Health
PDF
Pcn319 Contemporary Evidence on Global Economic Burden of Frontline Care for Peripheral T-cell Lymphoma
2019 · A.O. Ashaye, S. Abogunrin, et al. · Value in Health
PDF
Projected Impact of HCV Treatment on Near-Term Progression of Advanced Liver Disease in HCV-Infected Patients in a High Prevalence Birth Cohort
2012 · Jaime Rubin, Lisa McGarry, et al. · The American Journal of Gastroenterology
Works count: 26
Citation count: 144
H-index: 4
I10-index: 2
Year
Topic
Type